Skip to Content

Soft Economy Set to Weigh on Rollins’ Top Line in 2023, but Inflationary Pressures Should Ease

Rollins’ fair value estimate increased to $29.

""

Rollins delivered a strong finish to 2022 as its fourth-quarter performance capped off a second consecutive year of lofty pandemic-fueled organic revenue growth. Full-year EBIT of $493 million and EPS of $0.75 aligned with our estimates and represented respective growth of 10% and 5% year on year. Strong pest-control volume and outsize price increases—which successfully protected Rollins’ profit margins from cost inflation in 2022—contributed to the robust organic growth. Indeed, the sizable pricing uplift in combination with operating leverage led to a 20-basis-point year-on-year improvement in adjusted EBIT margin to 18.3% despite broad inflationary pressures that affected labor, materials and consumables, and vehicle expenses during 2022.

We expect the presently gloomy U.S. economic outlook to soften Rollins’ top-line growth somewhat in 2023. However, with the U.S. economy likely to recover in 2024, our long-term expectations for the wide-moat company are unchanged. We’ve increased our fair value estimate by 3.5% to $29 due to the time value of money. Still, the shares continue to screen expensively, trading at a 24% premium to our revised fair value estimate.

We anticipate a soft landing for the U.S. economy but still forecast meager economic growth of 1% in 2023, down from 2.1% in 2022. Against this cooling economic backdrop, we forecast Rollins’ organic top-line growth to slow to 4.4% in 2023 from a heightened 7.8% in 2022 as pest-control volume softens. Still, we expect robust earnings growth in 2023 as a combination of cost savings from the ongoing rollout of Rollins’ route optimization program and operating leverage—from organic and acquisitive revenue growth—widens operating profit margin by about 120 basis points to 19.5%. Accordingly, we forecast 2023 EBIT of $563 million and EPS of $0.85, representing year-on-year growth of 14% and 15%, respectively.

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.

More in Stocks

About the Author

Grant Slade

Senior Equity Analyst
More from Author

Grant Slade is a senior equity analyst, ESG, for Morningstar Holland BV, a wholly owned subsidiary of Morningstar, Inc. Alongside his focus on environmental, social, and governance equity research, Slade also covers U.K. homebuilding stocks.

Prior to his current role, Slade was a senior equity analyst for Morningstar Australasia where he covered building and construction materials, packaging, and other industrials stocks. Before joining Morningstar in 2018, Slade was an equity research analyst with Capital Dynamics, a global fund manager based across the Asia-Pacific region.

Slade holds a Master of Economic Analysis from the University of Sydney, and bachelor's degrees in economics and biotechnology from the Queensland University of Technology. He also holds the Chartered Financial Analyst® designation.

Sponsor Center